Title

Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

Document Type

Journal Article

Publication Date

9-1-2016

Journal

Neuro-oncology

Volume

18

Issue

9

Inclusive Pages

1319-1325

DOI

10.1093/neuonc/now047

Comments

This is an open access PubMed Central article. Click on link for full-text access.

Peer Reviewed

1

Open Access

1